These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 16678055)
1. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK; Tyson DR Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055 [TBL] [Abstract][Full Text] [Related]
2. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994 [TBL] [Abstract][Full Text] [Related]
5. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941 [TBL] [Abstract][Full Text] [Related]
6. Use of serological proteomic methods to find biomarkers associated with breast cancer. Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611 [TBL] [Abstract][Full Text] [Related]
8. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Fredolini C; Liotta LA; Petricoin EF Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. Sardana G; Jung K; Stephan C; Diamandis EP J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523 [TBL] [Abstract][Full Text] [Related]
10. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry]. Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834 [TBL] [Abstract][Full Text] [Related]
11. Analysis of prostate cancer by proteomics using tissue specimens. Liu AY; Zhang H; Sorensen CM; Diamond DL J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032 [TBL] [Abstract][Full Text] [Related]
12. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530 [TBL] [Abstract][Full Text] [Related]
13. Proteome analysis of prostate cancer. Kuruma H; Egawa S; Oh-Ishi M; Kodera Y; Maeda T Prostate Cancer Prostatic Dis; 2005; 8(1):14-21. PubMed ID: 15477873 [TBL] [Abstract][Full Text] [Related]
14. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer. Hirano T; Kato H Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067 [TBL] [Abstract][Full Text] [Related]
15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
16. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759 [TBL] [Abstract][Full Text] [Related]
17. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702 [TBL] [Abstract][Full Text] [Related]
18. Proteomics in the analysis of prostate cancer. Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127 [No Abstract] [Full Text] [Related]
19. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data. Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967 [TBL] [Abstract][Full Text] [Related]
20. Advanced proteomic technologies for cancer biomarker discovery. Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]